Hamiel Uri, Kurolap Alina, Gadot Chofit Chai, Mory Adi, Shira Anat Bar, Feldman Hagit Baris, Marom Daphna
Genetics Institute and Genomics Center, Sourasky Medical Center, 6 Weizmann Street, 6423906 Tel Aviv, Israel.
J Genet. 2025;104.
Smith-Magenis syndrome (SMS) is a complex genetic disorder characterized by developmental delay and a typical behavioral phenotype. Interstitial 17p11.2 deletions, which include the RAI1 gene are detected in >90% of patients, while single nucleotide variants (SNVs) are detected in the rest. The gene is encoded from exons 3 onwards, while exons 1-2 are noncoding. It is unclear whether genetic variants preceding exon 3 cause SMS. We evaluated a 15-month-old infant for developmental delay and infantile spasms who was found to carry a deletion encompassing exons 1-2 of . To determine whether the deletion of the noncoding exons 1-2 of the gene is associated with SMS and to elucidate the underlying mechanism of this association. A singleton exome-based gene panel was performed, followed by chromosomal-microarray (CMA) to confirm the results. Real time quantitative PCR (RT-qPCR) analysis was conducted to evaluate mRNA expression. CMA confirmed a de novo 737.8 kbp deletion on 17p11.2, which includes exons 1-2 of but spares exons 3 onwards. RT-qPCR analysis on RNA extracted from the patient, father and three unrelated controls revealed that the patient has haploinsufficiency. We show that deletion of the noncoding exons 1-2, which spares the gene's coding region, causes haploinsufficiency by eliminating regulatory elements, including the gene promoter, thus causing SMS and expanding the mutational spectrum of SMS.